Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Vallen Graham

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Annual Review of Medicine|January 19, 2017
Update on Alzheimer's Disease Therapy and Prevention StrategiesW Vallen Graham, Alessandra Bonito-Oliva, Thomas P Sakmar
Annual Review of Pathology|January 19, 2010
Epithelial barriers in homeostasis and diseaseAmanda M Marchiando, W Vallen Graham, Jerrold R Turner
Annals of the New York Academy of Sciences|June 23, 2009
No static at allW Vallen Graham, Amanda M Marchiando, Le Shen, et al.
Scientific Reports|February 22, 2017
Nucleobindin 1 binds to multiple types of pre-fibrillar amyloid and inhibits fibrillizationAlessandra Bonito-Oliva, Shahar Barbash, Thomas P Sakmar, et al.
Pharmaceutical Research|May 21, 2005
A strategy to identify stable membrane-permeant peptide inhibitors of myosin light chain kinaseSiân-Eleri Owens, W Vallen Graham, Dario Siccardi, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|February 9, 2011
Crystallization and preliminary X-ray analysis of the human long myosin light-chain kinase 1-specific domain IgCAM3W Vallen Graham, Andrew T Magis, Kate M Bailey, et al.
The Journal of Biological Chemistry|June 24, 2006
MAPKAPK-2 is a critical signaling intermediate in NHE3 activation following Na+-glucose cotransportZhihong Hu, Yingmin Wang, W Vallen Graham, et al.
Experimental Biology and Medicine (Maywood, N.J.)|April 3, 2003
Gastrointestinal and microbial responses to sulfate-supplemented drinking water in miceBart Deplancke, Kai Finster, W Vallen Graham, et al.
The American Journal of Pathology|February 1, 2005
Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expressionFengjun Wang, W Vallen Graham, Yingmin Wang, et al.
International Journal of Molecular Sciences|February 8, 2020
Contributions of Myosin Light Chain Kinase to Regulation of Epithelial Paracellular Permeability and Mucosal HomeostasisWei-Qi He, Jing Wang, Jian-Ying Sheng, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Annual Review of Medicine|January 19, 2017
Update on Alzheimer's Disease Therapy and Prevention StrategiesW Vallen Graham, Alessandra Bonito-Oliva, Thomas P Sakmar
Annual Review of Pathology|January 19, 2010
Epithelial barriers in homeostasis and diseaseAmanda M Marchiando, W Vallen Graham, Jerrold R Turner
Annals of the New York Academy of Sciences|June 23, 2009
No static at allW Vallen Graham, Amanda M Marchiando, Le Shen, et al.
Scientific Reports|February 22, 2017
Nucleobindin 1 binds to multiple types of pre-fibrillar amyloid and inhibits fibrillizationAlessandra Bonito-Oliva, Shahar Barbash, Thomas P Sakmar, et al.
Pharmaceutical Research|May 21, 2005
A strategy to identify stable membrane-permeant peptide inhibitors of myosin light chain kinaseSiân-Eleri Owens, W Vallen Graham, Dario Siccardi, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|February 9, 2011
Crystallization and preliminary X-ray analysis of the human long myosin light-chain kinase 1-specific domain IgCAM3W Vallen Graham, Andrew T Magis, Kate M Bailey, et al.
The Journal of Biological Chemistry|June 24, 2006
MAPKAPK-2 is a critical signaling intermediate in NHE3 activation following Na+-glucose cotransportZhihong Hu, Yingmin Wang, W Vallen Graham, et al.
Experimental Biology and Medicine (Maywood, N.J.)|April 3, 2003
Gastrointestinal and microbial responses to sulfate-supplemented drinking water in miceBart Deplancke, Kai Finster, W Vallen Graham, et al.
The American Journal of Pathology|February 1, 2005
Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expressionFengjun Wang, W Vallen Graham, Yingmin Wang, et al.
International Journal of Molecular Sciences|February 8, 2020
Contributions of Myosin Light Chain Kinase to Regulation of Epithelial Paracellular Permeability and Mucosal HomeostasisWei-Qi He, Jing Wang, Jian-Ying Sheng, et al.
Pageof 3